Acceder

Publicaciones - Control molecular de la proliferación y diferenciación

Cargando...
Castejon-Grinan M, Albers E, Simon-Carrasco L, Aguilera P, Sbroggio M, Pladevall-Morera D, Ingham A, Lim E, Guillen-Benitez A, Pietrini E, Lisby M, Hickson ID, Lopez-Contreras AJ. PICH deficiency limits the progression of MYC-induced B-cell lymphoma. Blood Cancer J. 2024 Jan 23;14(1):16. doi: 10.1038/s41408-024-00979-y. PubMed PMID: 38253636; PubMed Central PMCID: PMC10803365.
AÑO: 2024; IF: 12.9
Cerdido S., Abrisqueta M., Sánchez-Beltrán J., Lambertos A., Castejón-Griñán M., Muñoz C., Olivares C., García-Borrón J.C., Jiménez-Cervantes C., Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Letters. 28 January 2024. 581. 10.1016/j.canlet.2023.216484
AÑO: 2024; IF: 9.1
Castejon-Grinan M, Cerdido S, Sanchez-Beltran J, Lambertos A, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biol. 2024 Jun;72:103135. doi: 10.1016/j.redox.2024.103135. Epub 2024 Mar 26. PubMed PMID: 38565069; PubMed Central PMCID: PMC11002308.
AÑO: 2024; IF: 10.7
Stefanaki I., D'Ecclesiis O., Vignati S., Gaeta A., Kypreou K., Caini S., Gandini S., Nagore E., Sera F., Botta F., Newton-Bishop J., Polsky D., Lazovich D.A., Kanetsky P.A., Puig S., Gruis N.A., Landi M.T., Fargnoli M.C., Stratigos A., Guida G., Ghiorzo P., Menin C., García-Borrón J.C., Little J., Nan H., Raimondi S. Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project. Journal of the European Academy of Dermatology and Venereology. 2024. 10.1111/jdv.20380
AÑO: 2024; IF: 8.4
Cerdido S, Sanchez-Beltran J, Lambertos A, Abrisqueta M, Padilla L, Herraiz C, Olivares C, Jimenez-Cervantes C, Garcia-Borron JC. A Side-by-Side Comparison of Wildtype and Variant Melanocortin 1 Receptor Signaling with Emphasis on Protection against Oxidative Damage to DNA. Int J Mol Sci. 2023 Sep 21;24(18):14381. doi: 10.3390/ijms241814381. PubMed PMID: 37762683; PubMed Central PMCID: PMC10532403.
AÑO: 2023; IF: 4.9
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Control molecular de la proliferación y diferenciación